1. Home
  2. |Insights
  3. |The Current Suspension/Debarment Landscape

The Current Suspension/Debarment Landscape

Client Alert | less than 1 min read | 05.25.17

With the federal suspension/debarment processes becoming more collaborative, contractors find themselves facing new agencies and new (and, generally, longer-lasting) procedures when dealing with suspending and debarring officials. David Robbins, Angela Styles & Peter Eyre cover the most recent changes in federal suspension, debarment, and proactive disclosure practice in Not Your Grandfather’s Suspension & Debarment: How Contractors Can Prepare For and Defend Against Today’s Exclusions.

Contacts

Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...